Mirnext BV

MirNext BV is a spin-off of ACS Biomarker BV MirNext develops actionable and cost-effective miRNA based tests to improve diagnostic routine and clinical management of patients with symptoms of heart failure or coronary artery disease.

prof. dr. Yigal M. Pinto   Fotografie: Fred van Diem

Mirnext BV

Meibergdreef 5
1105 AZ  Amsterdam

Telefoon: 020 – 697 1087

info@mirnext.com